These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

470 related articles for article (PubMed ID: 24586506)

  • 1. MicroRNA-206: a potential circulating biomarker candidate for amyotrophic lateral sclerosis.
    Toivonen JM; Manzano R; Oliván S; Zaragoza P; García-Redondo A; Osta R
    PLoS One; 2014; 9(2):e89065. PubMed ID: 24586506
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preferential motor unit loss in the SOD1 G93A transgenic mouse model of amyotrophic lateral sclerosis.
    Hegedus J; Putman CT; Tyreman N; Gordon T
    J Physiol; 2008 Jul; 586(14):3337-51. PubMed ID: 18467368
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progressive impairment of CaV1.1 function in the skeletal muscle of mice expressing a mutant type 1 Cu/Zn superoxide dismutase (G93A) linked to amyotrophic lateral sclerosis.
    Beqollari D; Romberg CF; Dobrowolny G; Martini M; Voss AA; Musarò A; Bannister RA
    Skelet Muscle; 2016; 6():24. PubMed ID: 27340545
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Up-regulation of neural and cell cycle-related microRNAs in brain of amyotrophic lateral sclerosis mice at late disease stage.
    Marcuzzo S; Bonanno S; Kapetis D; Barzago C; Cavalcante P; D'Alessandro S; Mantegazza R; Bernasconi P
    Mol Brain; 2015 Jan; 8():5. PubMed ID: 25626686
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Properties of slow- and fast-twitch muscle fibres in a mouse model of amyotrophic lateral sclerosis.
    Atkin JD; Scott RL; West JM; Lopes E; Quah AK; Cheema SS
    Neuromuscul Disord; 2005 May; 15(5):377-88. PubMed ID: 15833433
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional over-load saves motor units in the SOD1-G93A transgenic mouse model of amyotrophic lateral sclerosis.
    Gordon T; Tyreman N; Li S; Putman CT; Hegedus J
    Neurobiol Dis; 2010 Feb; 37(2):412-22. PubMed ID: 19879358
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment with an antibody directed against Nogo-A delays disease progression in the SOD1G93A mouse model of Amyotrophic lateral sclerosis.
    Bros-Facer V; Krull D; Taylor A; Dick JR; Bates SA; Cleveland MS; Prinjha RK; Greensmith L
    Hum Mol Genet; 2014 Aug; 23(16):4187-200. PubMed ID: 24667415
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Skeletal muscle properties in a transgenic mouse model for amyotrophic lateral sclerosis: effects of creatine treatment.
    Derave W; Van Den Bosch L; Lemmens G; Eijnde BO; Robberecht W; Hespel P
    Neurobiol Dis; 2003 Aug; 13(3):264-72. PubMed ID: 12901841
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Muscle microRNA signatures as biomarkers of disease progression in amyotrophic lateral sclerosis.
    Si Y; Cui X; Crossman DK; Hao J; Kazamel M; Kwon Y; King PH
    Neurobiol Dis; 2018 Jun; 114():85-94. PubMed ID: 29486297
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Muscle fiber-type specific terminal Schwann cell pathology leads to sprouting deficits following partial denervation in SOD1
    Harrison JM; Rafuse VF
    Neurobiol Dis; 2020 Nov; 145():105052. PubMed ID: 32827689
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel behavioural characteristics of the superoxide dismutase 1 G93A (SOD1
    Kreilaus F; Guerra S; Masanetz R; Menne V; Yerbury J; Karl T
    Genes Brain Behav; 2020 Feb; 19(2):e12604. PubMed ID: 31412164
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Screening the expression characteristics of several miRNAs in G93A-SOD1 transgenic mouse: altered expression of miRNA-124 is associated with astrocyte differentiation by targeting Sox2 and Sox9.
    Zhou F; Zhang C; Guan Y; Chen Y; Lu Q; Jie L; Gao H; Du H; Zhang H; Liu Y; Wang X
    J Neurochem; 2018 Apr; 145(1):51-67. PubMed ID: 28960306
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dysregulation of Muscle-Specific MicroRNAs as Common Pathogenic Feature Associated with Muscle Atrophy in ALS, SMA and SBMA: Evidence from Animal Models and Human Patients.
    Malacarne C; Galbiati M; Giagnorio E; Cavalcante P; Salerno F; Andreetta F; Cagnoli C; Taiana M; Nizzardo M; Corti S; Pensato V; Venerando A; Gellera C; Fenu S; Pareyson D; Masson R; Maggi L; Dalla Bella E; Lauria G; Mantegazza R; Bernasconi P; Poletti A; Bonanno S; Marcuzzo S
    Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34073630
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sex-Dependent Changes to the Intestinal and Hepatic Abundance of Drug Transporters and Metabolizing Enzymes in the SOD1
    Koehn LM; Steele JR; Schittenhelm RB; Turner BJ; Nicolazzo JA
    Mol Pharm; 2024 Apr; 21(4):1756-1767. PubMed ID: 38415587
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intralingual Administration of AAVrh10-miR
    Lind LA; Andel EM; McCall AL; Dhindsa JS; Johnson KA; Stricklin OE; Mueller C; ElMallah MK; Lever TE; Nichols NL
    Hum Gene Ther; 2020 Aug; 31(15-16):828-838. PubMed ID: 32498636
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glycoprotein nonmetastatic melanoma protein B ameliorates skeletal muscle lesions in a SOD1G93A mouse model of amyotrophic lateral sclerosis.
    Nagahara Y; Shimazawa M; Tanaka H; Ono Y; Noda Y; Ohuchi K; Tsuruma K; Katsuno M; Sobue G; Hara H
    J Neurosci Res; 2015 Oct; 93(10):1552-66. PubMed ID: 26140698
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MiR-146a in ALS: Contribution to Early Peripheral Nerve Degeneration and Relevance as Disease Biomarker.
    Giagnorio E; Malacarne C; Cavalcante P; Scandiffio L; Cattaneo M; Pensato V; Gellera C; Riva N; Quattrini A; Dalla Bella E; Lauria G; Mantegazza R; Bonanno S; Marcuzzo S
    Int J Mol Sci; 2023 Feb; 24(5):. PubMed ID: 36902041
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fenretinide Beneficial Effects on Amyotrophic Lateral Sclerosis-associated SOD1
    Orienti I; Armida M; Dobrowolny G; Pepponi R; Sollazzini G; Pezzola A; Casola I; Musarò A; Popoli P; Potenza RL
    Neuroscience; 2021 Oct; 473():1-12. PubMed ID: 34363869
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SOD1
    Marton S; Miquel E; Acosta-Rodríguez J; Fontenla S; Libisch G; Cassina P
    ASN Neuro; 2023; 15():17590914231197527. PubMed ID: 37644868
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Time course of preferential motor unit loss in the SOD1 G93A mouse model of amyotrophic lateral sclerosis.
    Hegedus J; Putman CT; Gordon T
    Neurobiol Dis; 2007 Nov; 28(2):154-64. PubMed ID: 17766128
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.